Anti-reflux mucosal ablation (ARMA) as a novel minimally invasive treatment for severe gastroesophageal reflux disease in a child: the first pediatric case report - Quiz - MDSpire

Anti-reflux mucosal ablation (ARMA) as a novel minimally invasive treatment for severe gastroesophageal reflux disease in a child: the first pediatric case report

  • By

  • Jonas Povilavičius

  • Geistė Tubutytė

  • Kamilė Bagdonaitė

  • Audrius Dulskas

  • Arūnas Strumila

  • Austėja Račytė

  • June 1, 2026

  • 0 min

Share

Original Source(s)

Anti-reflux mucosal ablation (ARMA) as a novel minimally invasive treatment for severe gastroesophageal reflux disease in a child: the first pediatric case report

  • by Jonas Povilavičius, Geistė Tubutytė, Kamilė Bagdonaitė, Audrius Dulskas, Arūnas Strumila, Austėja Račytė

  • June 1, 2026

Related Content

Stool Withholding at School Among Children in the Netherlands

A Model for Predicting Recurrence of Acute Pancreatitis in Children Using Serological Markers in the Absence of Pancreaticobiliary Anomalies

Diabetes and cancer: clinical implications for integrated metabolic–oncologic care